ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Lynparza significantly reduces risk of disease worsening or death
europeanpharmaceuticalreview
June 12, 2017AstraZeneca presented positive results from its Phase III OlympiAD trial that showed a statistically-significant and clinically-meaningful improvement in progression-free survival (PFS) for patients treated with Lynparza (olaparib) tablets...
Pharma Sources Insight July 2025
